Showing results (111-120 of 773) with videos related to

Sort By:
Pageof 78
Journal of General Internal Medicine|February 28, 2009
Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy labelWilliam H Shrank, Patrick P Gleason, Claire Canning, et al.
Journal of the American Geriatrics Society|May 25, 2002
Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patientsPhilip S Wang, Raisa Levin, Sean Z Zhao, et al.
Kidney International|August 13, 2003
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgeryWolfgang C Winkelmayer, Robert J Glynn, Raisa Levin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarctionWolfgang C Winkelmayer, David M Charytan, Raisa Levin, et al.
Health Affairs (Project Hope)|February 5, 2014
Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparencyThomas J Hwang, Jerry Avorn, Daniel Carpenter, et al.
Health Affairs (Project Hope)|November 3, 2010
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherenceNiteesh K Choudhry, Michael A Fischer, Jerry Avorn, et al.
American Journal of Epidemiology|August 19, 2010
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation studyTil Stürmer, Kenneth J Rothman, Jerry Avorn, et al.
JAMA Internal Medicine|October 5, 2017
Strategies That Delay Market Entry of Generic DrugsKerstin Noëlle Vokinger, Aaron S Kesselheim, Jerry Avorn, et al.
Health Affairs (Project Hope)|January 20, 2017
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug MakersAaron S Kesselheim, Benjamin N Rome, Ameet Sarpatwari, et al.
BMJ (Clinical Research Ed.)|August 20, 2024
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional studyAriadna Tibau, Thomas J Hwang, Jerry Avorn, et al.
Pageof 78